Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 268 papers

Activation of the alternate renin-angiotensin system correlates with the clinical status in human cirrhosis and corrects post liver transplantation

Casey S, Schierwagen R, Mak KY, Klein S, Uschner F, Jansen C, Praktiknjo M, Meyer C, Thomas D, Herath C, Jones R, Trebicka J, Angus P.

J Clin Med 2019, 8(4): 419

DOI: 10.3390/jcm8040419

Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis

Trebicka J, Amoros A, Pitarch C, Titos E, Alcaraz-Quiles J, Schierwagen R, Deulofeu C, Fernandez-Gomez J, Piano S, Caraceni P, Oettl K, Sola E, Laleman W, McNaughtan J, Mookerjee RP, Coenraad MJ, Welzel T, Steib C, Garcia R, Gustot T, Rodriguez Gandia MA, Bañares R, Albillos A, Zeuzem S, Vargas V, Saliba F, Nevens F, Alessandria C, de Gottardi A, Zoller H, Ginès P, Sauerbruch T, Gerbes A, Stauber RE, Bernardi M, Angeli P, Pavesi M, Moreau R, Clària J, Jalan R, Arroyo V.

Front Immunol 2019, 10: 476

DOI: 10.3389/fimmu.2019.00476

Circulating microbiome in blood of different circulatory compartments

Schierwagen R, Alvarez-Silva C, Madsen MSA, Kolbe CC, Meyer C, Thomas D, Uschner FE, Magdaleno F, Jansen C, Pohlmann A, Praktiknjo M, Hischebeth GT, Molitor E, Latz E, Lelouvier B, Trebicka J, Arumugam M.

Gut 2019, 68(3): 578–580

DOI: 10.1136/gutjnl-2018-316227

Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe

Fernández J, Prado V, Trebicka J, Amoros A, Gustot T, Wiest R, Deulofeu C, Garcia E, Acevedo J, Fuhrmann V, Durand F, Sánchez C, Papp M, Caraceni P, Vargas V, Bañares R, Piano S, Janicko M, Albillos A, Alessandria C, Soriano G, Welzel TM, Laleman W, Gerbes A, De Gottardi A, Merli M, Coenraad M, Saliba F, Pavesi M, Jalan R, Ginès P, Angeli P, Arroyo V; European Foundation for the Study of Chronic Liver Failure (EF-Clif).

J Hepatol 2019, 70(3): 398–411

DOI: 10.1016/j.jhep.2018.10.027

Prioritization of therapeutic targets and trial design in cirrhotic portal hypertension

Abraldes JG, Trebicka J, Chalasani N, D'Amico G, Rockey DC, Shah VH, Bosch J, Garcia-Tsao G.

Hepatology 2019, 69(3): 1287–1299

DOI: 10.1002/hep.30314

Acute-on-chronic liver failure in patients with alcohol-related liver disease

Gustot T, Jalan R.

J Hepatol 2019, 70(2): 319–327

DOI: 10.1016/j.jhep.2018.12.008

Agreement of surgical blood loss estimation methods

Jaramillo S, Montane-Muntane M, Capitan D, Aguilar F, Vilaseca A, Blasi A, Navarro-Ripoll R.

Transfusion 2019, 59(2): 508–515

DOI: 10.1111/trf.15052

Left ventricular longitudinal contractility predicts acute-on-chronic liver failure development and mortality after transjugular intrahepatic portosystemic shunt

Jansen C, Schröder A, Schueler R, Lehmann J, Praktiknjo M, Uschner FE, Schierwagen R, Thomas D, Monteiro S, Nickenig G, Strassburg CP, Meyer C, Arroyo V, Hammerstingl C, Trebicka J.

Hepatol Commun 2019, 3(3): 340–347

DOI: 10.1002/hep4.1308

Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome

Lopategi A, Flores-Costa R, Rius B, López-Vicario C, Alcaraz-Quiles J, Titos E, Clària J.

J Leukoc Biol 2019, 105(1): 25–36

DOI: 10.1002/JLB.3HI0517-206RR

Management of acute liver failure – Clinical guideline from the Catalan Society of Digestology

Escorsell À, Castellote J, Sánchez-Delgado J, Charco R, Crespo G, Fernández J.

Gastroenterol Hepatol 2019, 42(1): 51–64

DOI: 10.1016/j.gastrohep.2018.07.013